Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

hVIVO plc

OPORFPNK
Healthcare
Biotechnology
$0.09
$0.00(0.00%)
U.S. Market opens in 8h 16m

hVIVO plc Fundamental Analysis

hVIVO plc (OPORF) shows strong financial fundamentals with a PE ratio of 6.61, profit margin of 10.37%, and ROE of 11.97%. The company generates $0.1B in annual revenue with strong year-over-year growth of 11.92%.

Key Strengths

Cash Position49.18%
PEG Ratio-0.18
Current Ratio1.60

Areas of Concern

No major concerns flagged.
We analyze OPORF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 56.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
56.3/100

We analyze OPORF's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPORF struggles to generate sufficient returns from assets.

ROA > 10%
6.17%

Valuation Score

Excellent

OPORF trades at attractive valuation levels.

PE < 25
6.61
PEG Ratio < 2
-0.18

Growth Score

Moderate

OPORF shows steady but slowing expansion.

Revenue Growth > 5%
11.92%
EPS Growth > 10%
-34.03%

Financial Health Score

Excellent

OPORF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.34
Current Ratio > 1
1.60

Profitability Score

Weak

OPORF struggles to sustain strong margins.

ROE > 15%
11.97%
Net Margin ≥ 15%
10.37%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPORF Expensive or Cheap?

P/E Ratio

OPORF trades at 6.61 times earnings. This suggests potential undervaluation.

6.61

PEG Ratio

When adjusting for growth, OPORF's PEG of -0.18 indicates potential undervaluation.

-0.18

Price to Book

The market values hVIVO plc at 0.80 times its book value. This may indicate undervaluation.

0.80

EV/EBITDA

Enterprise value stands at 4.32 times EBITDA. This is generally considered low.

4.32

How Well Does OPORF Make Money?

Net Profit Margin

For every $100 in sales, hVIVO plc keeps $10.37 as profit after all expenses.

10.37%

Operating Margin

Core operations generate 10.98 in profit for every $100 in revenue, before interest and taxes.

10.98%

ROE

Management delivers $11.97 in profit for every $100 of shareholder equity.

11.97%

ROA

hVIVO plc generates $6.17 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.17%

Following the Money - Real Cash Generation

Operating Cash Flow

hVIVO plc generates limited operating cash flow of $234.90K, signaling weaker underlying cash strength.

$234.90K

Free Cash Flow

hVIVO plc generates weak or negative free cash flow of $-1.27M, restricting financial flexibility.

$-1.27M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

OPORF converts -2.33% of its market value into free cash.

-2.33%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

6.61

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.18

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.80

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.86

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.34

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.12

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How OPORF Stacks Against Its Sector Peers

MetricOPORF ValueSector AveragePerformance
P/E Ratio6.6129.45 Better (Cheaper)
ROE11.97%779.00% Weak
Net Margin10.37%-24936.00% (disorted) Strong
Debt/Equity0.340.26 Weak (High Leverage)
Current Ratio1.604.65 Neutral
ROA6.17%-19344.00% (disorted) Weak

OPORF outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews hVIVO plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

363.43%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

146.24%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

190.29%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ